An Ominous And Familiar Sign In The US IPO Market

An Ominous And Familiar Sign In The US IPO Market
2488716 / Pixabay

As the title suggests, a familiar if ominous sign has emerged in the US IPO market.  As I’ve previously written on a number of times, studying trends and statistics in IPO statistics (initial public offering) can yield key insights on the state of the equity market as a whole and the resultant risk vs opportunity outlook.

Get Our Activist Investing Case Study!

Get the entire 10-part series on our in-depth study on activist investing in PDF. Save it to your desktop, read it on your tablet, or print it out to read anywhere! Sign up below!

Check out our H2 hedge fund letters here.


Jim Chanos Unveils Lastest Short As Fund Manager Bets On Further Market Declines

Data 1639507577Jim Chanos has a new short target in his sights. Earlier this week, the hedge fund manager disclosed that he is betting against "legacy" data centers that face growing competition from the trio of technology giants, which have previously been their biggest customers. The fund manager, who is best known for his winning bet against Read More

The chart in today's blog comes from a discussion on the trends in the US IPO market from the Weekly Macro Themes report. That discussion aside from the negative earnings aspect, also looked at median age of IPO, proportion of foreign IPOs, and the pace of withdrawals and filings.

As alluded to, the chart shows the proportion of US IPOs with negative earnings.

US IPO Market

At 76% the proportion of US IPOs with "earnings less than 0"... i.e. loss making companies, was the highest level since 1999 (second equal to the absolute highest in the year 2000). It's an intriguing statistic and one that instantly evokes parallels to the dot com mania.  Certainly, this is the sort of thing you typically see toward the end of a market cycle.

Diving into the detail - note the data is from the fine work conducted by Jay R Ritter of the University of Florida - the top culprit was Biotech companies, with 97% of biotech IPOs in the loss making camp.  Second place, no prizes for guessing, was Technology companies at 83%.  But interestingly enough that left 'all other companies' at 57% - which is actually a record high.

So it adds to a number of signs that we are "late cycle", whether it's the business cycle or the market cycle. But then again, late-cycle does not necessarily mean end-of-cycle, and as the year 2000 showed us so dramatically, these things can overshoot.  I would not say a speculative overshoot is my base case, but from a risk management standpoint (thinking about both sides of the coin), it's not something you rule out, particularly when you see animal spirits truly getting to work.

This article originally appeared as a submission at See It Market

Follow us on:



Article by Callum Thomas, Top Down Charts

Updated on

Topdown Charts: "chart driven macro insights" Based in Queenstown, New Zealand, Topdown Charts brings you independent research and analysis on global macro themes and trends. Topdown Charts covers multiple economies, markets, and asset classes with a distinct chart-driven focus. We are not bound by technical or fundamental dogma, and instead look to leverage any relevant factor to capture the theme. As such, here you will find some posts that are purely technical strategy, some that just cover economics and data, and some posts that use multiple inputs to tell the story and identify the opportunities. Callum Thomas Head of Research Callum is the founder of Topdown Charts. He previously worked in investment strategy and asset allocation at AMP Capital in the Multi-Asset division. Callum has a passion for global macro investing and has developed strong research and analytical expertise across economies and asset classes. Callum's approach is to utilise a blend of factors to inform the macro view.
Previous article Apple to unveil iOS 12, macOS 10.14, watchOS 5 at WWDC 2018 on June 4
Next article Failure In The S&P 500 – Alert!

No posts to display